Share:
Net Revenues: $97.4 million, a 20% increase
Net Income: $17.3 million, a 15.9 million increase,
Adjusted EBITDA: $26.2 million, a 44% increase, and
Adjusted EBITDA margin of 27%, a 4.4% increase
Company Reaffirms Full Year 2021 Guidance:
Net Revenues of $107 million - $110 million,
Adjusted EBITDA of $29 million - $30 million, and
Operating Cash Flow of $21 million - $23 million.
ROCHESTER HILLS, Michigan, March 17, 2021 (GLOBE NEWSWIRE) --
InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2020.
Fourth Quarter Highlights: